# BioCorRx Inc. (BICX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BICX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 302.5K | $ -1.80M | $ -873.3K | $ 7.66M | $ -12.22M |
| 2025 | $ 816.3K | $ -3.52M | $ -2.35M | $ 2.13M | $ -11.22M |
| 2024 | $ 8.1K | $ -5.37M | $ -1.15M | $ 7.11M | $ -12.12M |
| 2023 | $ 96.4K | $ -4.07M | $ -2.00M | $ 1.81M | $ -9.82M |
| 2022 | $ 238.9K | $ -5.75M | $ -2.28M | $ 1.68M | $ -8.08M |
| 2021 | $ 57.4K | $ -6.40M | $ -4.26M | $ 1.77M | $ -6.84M |
| 2020 | $ 156.2K | $ -4.42M | $ -2.75M | $ 955.6K | $ -4.09M |
| 2019 | $ 310.1K | $ -7.80M | $ -3.95M | $ 893.7K | $ -977.7K |
| 2018 | $ 497.4K | $ -8.60M | $ -2.48M | $ 4.36M | $ -5.63M |
| 2017 | $ 885.4K | $ -40.02M | $ -3.43M | $ 2.20M | $ -3.89M |
| 2016 | $ 965.5K | $ -8.12M | $ -3.19M | $ 1.16M | $ -8.13M |
| 2015 | $ 1.30M | $ -6.55M | $ 67.2K | $ 1.76M | $ -3.28M |
| 2014 | $ 1.65M | $ -4.42B | $ 236.2K | $ 764.9K | $ 306.3K |
| 2013 | $ 1.02B | $ -5.46B | $ 147.1K | $ 908.3K | $ 222.8K |
| 2012 | $ 1.25M | $ -1.28B | $ -1.34M | $ 101.4K | $ 2.84M |
| 2011 | $ 1.13M | $ -600.8K | $ -197.9K | $ 191.9K | $ 3.49M |
| 2010 | $ 0 | $ -35.0K | $ -23.5K | $ 0 | $ 4.04M |
| 2009 | $ 0 | $ -21.4K | $ -11.7K | $ 280 | $ -3.0K |
| 2008 | $ 0 | $ -15.2K | $ -1.6K | $ 280 | $ 41 |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.63 |
| Liabilities / Eq | -1.18 |
| Current Ratio | 0.07 |

## Other views

- [Metrics](https://sponda.capital/en/BICX.md)
- [Charts](https://sponda.capital/en/BICX/charts.md)
- [Compare](https://sponda.capital/en/BICX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.